Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aclacinomycin A stabilizes topoisomerase I covalent complexes.

Cancer research - 15 Oct 1997

Nitiss J L, Pourquier P, Pommier Y

Abstract excerpt

Aclacinomycin A (aclarubicin) is an anthracycline anticancer agent with demonstrated activity against both leukemias and solid tumors. Previous results suggested that a major activity of aclacinomycin A is the inhibition of topoisomerase II catalytic activity. We have applied a yeast system to test whether aclacinomycin A is a topoisomerase II inhibitor in vivo and to test whether we could identify other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to DNA Topoisomerases, Type I
Share to DNA Topoisomerases, Type II

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Kinetics

Share to Oligodeoxyribonucleotides

Share to Saccharomyces cerevisiae

Share to Substrate Specificity

Source

Identifiers

PMID: 9377570

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aclacinomycin A stabilizes topoisomerase I covalent complexes.PMID 9377570Read ↗

Human DNA topoisomerase IIalpha-dependent DNA cleavage and yeast cell killing by anthracycline analogues.Semantic proximity Read ↗

Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs.Semantic proximity Read ↗

Yeast as a genetic model system for studying topoisomerase inhibitors.Semantic proximity Read ↗

Studying DNA topoisomerase I-targeted drugs in the yeast. Saccharomyces cerevisiae.Semantic proximity Read ↗

Using yeast to study resistance to topoisomerase II-targeting drugs.Semantic proximity Read ↗

BRCA1- and BRCA2-Deficient Cells Are Sensitive to Etoposide-Induced DNA Double-Strand Breaks via Topoisomerase IISemantic proximity Read ↗

Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2 beta construct allows the study of topoisomerase II beta inhibitors in yeast.Semantic proximity Read ↗

Modulation of drug sensitivity in yeast cells by the ATP-binding domain of human DNA topoisomerase IIalpha.Semantic proximity Read ↗

Modulation of radiation response by inhibiting topoisomerase II catalytic activity.Semantic proximity Read ↗

A New Antitumor Agent Amrubicin Induces Cell Growth Inhibition by Stabilizing Topoisomerase II‐DNA ComplexSemantic proximity Read ↗

Mutations in the gyrB domain of eukaryotic topoisomerase II can lead to partially dominant resistance to etoposide and amsacrine.Semantic proximity Read ↗

Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase II.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.